Over the past four years, INCATE has been supporting early-stage ventures working on innovations to address the challenge of antimicrobial resistance (AMR). INCATE's portfolio spans a wide range of innovative solutions, and the progress of [...]
More news
Photo credits: Phiogen PHIOGEN, a Texas-based venture developing off-the-shelf live biotherapeutic products, is excited [...]
Photo credits: INCATE Cavenagh Health exists to foster innovation and support the creation of new [...]
Antimicrobial resistance (AMR) is a global growing threat. Only through closer collaboration across all [...]
September 19th, 2024 – INCATE, the INCubator for Antibacterial Therapies in Europe, is glad to [...]
September 10th, 2024 – INCATE, the INCubator for Antibacterial Therapies in Europe, is pleased [...]
September 2nd, 2024 - INCATE (the INCubator for Antibacterial Therapies in Europe) is celebrating its [...]
The INCATE Selection Committee selected the new 6 ventures for Stage I support. Meet [...]
The 10th edition of the AMR World Congress, set to take place on September 5th-6th [...]
